Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
Beliebteste Broker
News
- 24.05. - 13:05 Uhr
Pulmatrix Selected to Present at the Annual Biotechnology Innovation Organization (BIO) International Convention
Presentation will showcase Company's patented iSPERSE™ technology and positive topline results from Phase 1 study of PUR3100 for acute migraine LEXINGTON, Mass. , May 24, 2023 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and central nervous system disease using its patented iSPERSE™ technology, today announced that management will present at the annual Biotechnology Innovation Organization (BIO) International Convention, to be held in-person in Boston, MA, June 5 - 8, 2023. » Mehr auf prnewswire.com
- 23.01. - 14:05 Uhr
Pulmatrix to Present Data on PUR1800 at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology
LEXINGTON, Mass. , Jan. 23, 2023 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease using its patented iSPERSE™ technology, today announced the acceptance of an abstract for presentation at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, to be held February 24-27, 2023 in San Antonio, Texas. » Mehr auf prnewswire.com
- 01.03. - 15:59 Uhr
Which U.S. Companies Are Cutting Ties With Russia? See Latest List.
U.S. companies are cutting ties with Russia due to the war with Ukraine and we're going over which ones traders need to know about. The post Which U.S. Companies Are Cutting Ties With Russia? » Mehr auf investorplace.com
Unternehmenszahlen
(EUR) | Sep. 2023 | |
---|---|---|
Umsatz | 1,66 Mio | 13,27% |
Bruttoeinkommen | 1,25 Mio | 17,18% |
Nettoeinkommen | 3,56 Mio | 28,70% |
EBITDA | 3,72 Mio | 22,58% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 5,93 Mio € |
Anzahl Aktien | 3,65 Mio |
52 Wochen-Hoch/Tief | 2,92 € - 1,44 € |
Dividenden | Nein |
Beta | 0,94 |
KGV (PE Ratio) | 0,40 |
KGWV (PEG Ratio) | 0,04 |
KBV (PB Ratio) | 0,32 |
KUV (PS Ratio) | 0,94 |
Unternehmensprofil
Name | Pulmatrix |
CEO | Teofilo David Raad MBA |
Website | |
Mitarbeiter | 28 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | PULM |
Assets entdecken
Shareholder von Pulmatrix investieren auch in folgende Assets